Cigna Subrogation Defense: Plan Language Analysis and Pharmacy Lien Protection in PI Settlements
James Wong — Founder & Pharmacist, LienScripts | March 26, 2025 | 8 min read
Cigna — now part of The Cigna Group alongside Express Scripts — administers both fully insured and self-funded health plans with active subrogation programs. Defending against Cigna subrogation requires careful plan language analysis, application of the common fund doctrine, and strategic use of pharmacy liens to keep injury medications outside the subrogation demand entirely.
A pharmacy lien is a legal claim against personal injury settlement proceeds for prescription medications provided on credit. Cigna's subrogation program targets PI settlements to recover benefits paid for injury-related medical care. Pharmacy liens from LienScripts fall entirely outside Cigna's subrogation reach because Cigna never paid for lien-dispensed medications — the lien pharmacy extended credit directly to the patient.
- Cigna's subrogation program pursues recovery from PI settlements through a dedicated recovery unit, often using third-party vendors
- Plan language analysis is the critical first step — Cigna administers plans with varying subrogation provisions, and the specific language drives the available defenses
- The common fund doctrine reduces Cigna's recovery by requiring the plan to share in attorney fees that created the settlement fund
- Pharmacy liens from LienScripts are structurally independent of Cigna's subrogation interest because no insurance payment was ever made for lien-dispensed medications
- The Cigna-Express Scripts integration means pharmacy benefits and medical benefits may flow through the same corporate family, making clear separation of lien-dispensed medications important
This post is for informational purposes only and does not constitute legal advice.
Cigna's Subrogation Program and Recovery Process
Cigna's subrogation operations are managed through its recovery unit, which identifies plan members with injury-related treatment and pursues reimbursement from PI settlements. The process follows a standard pattern:
- Identification. Cigna's claims data flags injury-related treatment using ICD codes that suggest a third-party claim.
- Lien notice. Cigna or its subrogation vendor contacts the plan member and attorney to assert a recovery interest.
- Benefits-paid inventory. Cigna compiles a list of all medical and pharmacy benefits paid for the injury.
- Settlement monitoring. Cigna tracks the case and expects notice of settlement.
- Recovery demand. Upon settlement, Cigna issues a formal reimbursement demand.
- Negotiation. The attorney presents applicable defenses and negotiates a reduced amount.
Cigna frequently uses third-party subrogation vendors — including Rawlings & Associates (now part of Conduent) and others. If you receive a subrogation notice from a vendor rather than Cigna directly, verify the relationship and confirm the benefits-paid figures against Cigna's records.
[!KEY] Cigna's subrogation vendors may present demands that include items unrelated to the accident or pharmacy benefits that were actually provided through a lien arrangement. Verify every line item against the medical records and the lien pharmacy's dispensing history.
Plan Language Analysis: The Foundation of Cigna Subrogation Defense
Cigna administers multiple plan types with different subrogation provisions. The defense strategy depends entirely on the plan language:
Fully Insured Cigna Plans
State insurance law governs. Available defenses include:
- Made-whole doctrine. The plaintiff's right to full compensation takes priority over Cigna's recovery.
- State anti-subrogation statutes. Some states prohibit or limit health insurer subrogation for fully insured plans.
- Common fund doctrine. Cigna shares proportionately in the attorney fees that created the recovery.
Self-Funded ERISA Plans Administered by Cigna
ERISA preempts state insurance law. The plan document controls. Defense strategy:
- Plan document review. Look for gaps — provisions that do not expressly address made-whole, common fund, or fee allocation.
- Common fund under McCutchen. If the plan is silent on fee allocation, the common fund doctrine applies as an equitable gap-filler.
- Causation challenges. Review the benefits-paid list against medical records to identify items unrelated to the accident.
- Montanile defense. If settlement proceeds have been dissipated, the plan's equitable lien may not reach them.
According to James Wong, PharmD, founder of LienScripts, "Cigna's plan documents vary significantly in their subrogation provisions. Some plans have aggressive reimbursement language that rejects every equitable defense; others have gaps that create opportunities. The plan document is the first document to read — before the medical records, before the benefits-paid list."
[!TIP] Request the complete plan document and Summary Plan Description under ERISA section 104(b)(4) as soon as you identify Cigna coverage. The plan administrator must provide it within 30 days. Do not rely on the SPD alone — the full plan document may contain different or more detailed subrogation provisions.
The Common Fund Doctrine and Cigna
The common fund doctrine is often the most effective reduction tool for Cigna subrogation demands, particularly for self-funded plans where state-law made-whole is preempted.
For fully insured plans: The common fund doctrine operates under state law and typically reduces Cigna's demand by the proportionate share of attorney fees (often 33-40%).
For self-funded ERISA plans: Under US Airways v. McCutchen (2013), the common fund doctrine applies when the plan document does not expressly address allocation of attorney fees. If Cigna's plan document rejects common fund explicitly, McCutchen does not override that language. If the plan is silent, the reduction is available.
Calculating the common fund reduction:
- Determine the total attorney fee percentage.
- Apply that percentage to Cigna's gross subrogation demand.
- Reduce the demand by the resulting amount.
- Present the calculation to Cigna's recovery unit in a single written submission alongside any other defenses.
[!KEY] Submit a single, organized reduction request to Cigna's recovery unit that addresses all available defenses simultaneously — common fund, made-whole (if applicable), and causation challenges. Sequential submissions delay resolution and may result in less favorable outcomes.
The Cigna-Express Scripts Integration
Cigna's merger with Express Scripts created one of the largest integrated health services companies. For PI attorneys, this means:
Medical and pharmacy benefits under one roof. When the employer uses Cigna for health coverage and Express Scripts as the PBM, both medical and pharmacy benefits may appear in the subrogation demand.
Lien-dispensed medications are still independent. Medications provided by a lien pharmacy through LienScripts are never processed through Express Scripts, never appear in Cigna's claims data, and are not part of the subrogation demand — regardless of the Cigna-Express Scripts integration.
Verification is critical. When reviewing Cigna's benefits-paid list, confirm that any pharmacy line items were actually processed through the Express Scripts benefit. Lien-dispensed medications should not appear in this data. If they do, challenge the inclusion.
LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. The MERIT report creates a clear record of which medications were provided through the pharmacy lien — separate from any medications processed through the client's Cigna/Express Scripts benefit.
As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The Cigna-Express Scripts integration means the subrogation demand may include both medical and pharmacy claims. The MERIT report makes the separation clear — lien-dispensed medications are documented independently and were never processed through Express Scripts."
Why Pharmacy Liens Fall Outside Cigna's Subrogation
Regardless of whether the plan is fully insured or ERISA self-funded:
- Lien medications are not billed to Cigna. The pharmacy extends credit directly to the patient.
- No Cigna payment exists. There is nothing for Cigna to recover.
- The pharmacy lien is resolved independently. The attorney negotiates with LienScripts, not Cigna.
- ERISA preemption is irrelevant. The plan has no interest in medications it never paid for.
[!TIP] Enrolling clients in the LienScripts pharmacy lien program at intake keeps all injury medications outside Cigna's claims system from the start. This prevents any possibility of pharmacy costs appearing in the subrogation demand and eliminates the need to dispute pharmacy line items after the fact.
Practical Steps for Attorneys
- Identify Cigna coverage at intake. Ask about employer-sponsored health benefits and pharmacy benefits.
- Determine plan type. Request the SPD and plan document to confirm fully insured vs. self-funded.
- Enroll with LienScripts. Keep injury medications outside Cigna's claims system.
- Request the benefits-paid list. Review every line item against medical records for causation.
- Analyze plan language for defense opportunities. Common fund silence, made-whole gaps, fee allocation provisions.
- Submit a single organized reduction request. Common fund, causation, and made-whole (if applicable) together.
- Resolve the pharmacy lien separately. Obtain written release from both Cigna and LienScripts before disbursement.
Key Takeaway
Cigna subrogation defense requires careful plan language analysis. For fully insured plans, state-law made-whole and common fund doctrines provide significant reduction tools. For self-funded ERISA plans, the plan document controls and defenses are narrower — but the common fund doctrine under McCutchen remains available when the plan is silent on fee allocation. Pharmacy liens from LienScripts are entirely outside Cigna's subrogation interest. Enrolling clients at intake and resolving pharmacy lien costs independently maximizes the client's net recovery.
Related Resources
- Aetna Subrogation and Pharmacy Liens in PI Settlements
- Aetna ERISA Subrogation and Pharmacy Lien Priority
- UHC Subrogation and Pharmacy Liens
- Blue Cross Subrogation and Pharmacy Liens
Frequently Asked Questions
Does Cigna's subrogation interest include pharmacy lien costs?
No. Cigna's subrogation interest covers only benefits the plan actually paid. Medications dispensed through a pharmacy lien arrangement are never billed to Cigna or processed through Express Scripts. There is no Cigna payment to recover on lien-dispensed prescriptions. The pharmacy lien is resolved through a separate process with LienScripts.
How does the Cigna-Express Scripts merger affect subrogation?
The merger means both medical and pharmacy benefits may flow through the same corporate family and appear in Cigna's subrogation demand. Medications dispensed through a lien pharmacy — not processed through Express Scripts — remain outside this demand. Verify that any pharmacy line items in the benefits-paid list were actually processed through the Express Scripts benefit.
Can the common fund doctrine reduce Cigna's subrogation demand?
For fully insured plans, yes — the common fund doctrine operates under state law and typically reduces the demand by the proportionate share of attorney fees. For self-funded ERISA plans, the common fund doctrine applies under McCutchen (2013) when the plan document is silent on fee allocation. If the plan expressly rejects common fund, McCutchen does not override that language.